Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Adenocarcinoma Stories

2011-11-17 10:18:10

Weill Cornell physician-scientists say this vulnerability can be attacked by a targeted drug already in clinical trials to treat other types of cancers An international team of researchers led by clinicians at Weill Cornell Medical College have discovered a genetic Achilles' heel in an aggressive type of prostate cancer -- a vulnerability they say can be attacked by a targeted drug that is already in clinical trials to treat other types of cancers. In today's issue of Cancer Discovery,...

2011-10-28 02:00:00

INDIANAPOLIS, Oct. 28, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has granted approval for the use of ALIMTA® (pemetrexed for injection) as a single agent for continuation maintenance therapy in patients with a particular type of lung cancer, called advanced nonsquamous non-small cell lung cancer (NSCLC). The approval is based on clinical trial results showing an improvement in progression-free survival, as well as...

2011-10-26 13:30:00

Novel study finds signet cell histology is far more prevalent in rectal cancer patients under age 40 SAN FRANCISCO, Oct. 26, 2011 /PRNewswire-USNewswire/ -- University of Minnesota surgeons have confirmed a rising trend in rectal cancer in people age 40 and younger in recent years. While a previous 2010 study in the journal CANCER also found a recent rise in adenocarcinoma of the rectum in younger patients, (1) the University of Minnesota surgeons report that their study is the first to...

2011-09-26 12:00:00

INDIANAPOLIS, Sept. 26, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a new subgroup analysis of data from the pivotal Phase III PARAMOUNT study showed that continuation maintenance therapy with ALIMTA(® )(pemetrexed for injection) also reduces the risk of disease progression in patients aged 70 years or older with advanced nonsquamous non-small cell lung cancer (NSCLC), the most common type of lung cancer. Results from the new analysis...

2011-09-26 07:00:00

INDIANAPOLIS, Sept. 26, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of ALIMTA® (pemetrexed for injection) as continuation maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer (NSCLC). Positive opinions from the CHMP are reviewed by the European Commission, which then decides on...

2011-09-01 12:48:20

The nature of the connective tissue surrounding lung cancer nests can help predict the aggressiveness of squamous cell carcinoma, according to research published in the September issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC). Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths worldwide; its two major subtypes are adenocarcinoma and squamous cell carcinoma (SqCC). Although...

2011-09-01 12:19:27

Study published in The American Journal of Pathology The first report of the presence of alternative lengthening of telomeres (ALT) in cancers arising from the bladder, cervix, endometrium, esophagus, gallbladder, liver, and lung was published today in The American Journal of Pathology. The presence of ALT in carcinomas can be used as a diagnostic marker and has implications for the development of anti-cancer drug therapies. Telomeres are nucleoprotein complexes located at the ends of...

2011-07-18 16:33:54

Medically treated patients with mild or no symptoms of gastroesophageal reflux disease (GERD) are at higher risk for developing esophageal cancer than those with severe GERD symptoms, according to a University of Pittsburgh study published in the current issue of Archives of Surgery. Many patients who develop adenocarcinoma, a common form of esophageal cancer, are unaware that they have Barrett's esophagus "“ a change in the cells lining the esophagus often due to repeated stomach acid...

2011-06-30 19:17:03

UNC completes miRNA and array analysis As part of The Cancer Genome Atlas (TCGA) projectIcon indicating that a link will open an external site., UNC Lineberger researchers have contributed to the most comprehensive and integrated view of cancer genes for any cancer type produced to date. The UNC team, which includes Charles Perou, PhD, professor of pathology and laboratory medicine and genetics, Neil Hayes, MD, associate professor of hematology/oncology, and Katie Hoadley, PhD, Research...

2011-06-30 07:04:44

(Ivanhoe Newswire) "“ A key for early diagnosis of cancer and personalized medicine is the order of genetic aberrations - deviations or irregularity - in individual cancers. Now, scientists have begun to reveal the order of mutations that lead to cancer. "We know that each cancer is a collection of genetic malfunctions," Raymond Cho, Ph.D., assistant clinical professor in the department of dermatology at the University of California, San Francisco, was quoted as saying. "We now know it...